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A B S T R A C T
Background
Umbilical artery catheters are often used in unwell neonates. Infection related to the use of these catheters may cause significant
morbidity and mortality. The use of prophylactic antibiotics has been advocated for all newborns with umbilical artery catheters in
order to reduce the risk of colonisation and acquired infection. Countering this is the possibility that harm may outweigh benefit.
Objectives
The primary objective was to assess whether prophylactic antibiotics, in neonates with umbilical artery catheters, reduce mortality
and morbidity. In separate comparisons, we planned to review two different policies regarding the prophylactic use of antibiotics in
neonates with umbilical artery catheters: 1) among neonates with umbilical artery catheters, a policy of prophylactic antibiotics for the
duration of catheterisation (or other fixed duration of antibiotic treatment) versus placebo or no treatment; 2) among neonates with
umbilical artery catheters who had been started on antibiotics at the time of catheterisation but whose initial cultures to rule out sepsis
are negative, a policy of continuing versus discontinuing prophylactic antibiotics.
Search strategy
We searched MEDLINE (January 1966 to February 2004), CINAHL (1982 to February 2004), the Cochrane Central Register of
Controlled Trials (CENTRAL, The Cochrane Library, Issue 1, 2004), the Cochrane Neonatal Group Specialised Register and reference
lists of articles.
Selection criteria
Randomised controlled trials of adequate quality in which newborn infants with umbilical artery catheters are randomised to receive
prophylactic antibiotics versus placebo or no treatment.
Data collection and analysis
Two reviewers independently assessed trial quality.
Main results
No study met the criteria for inclusion in this review.
Authors’ conclusions
There is no evidence from randomised trials to support or refute the use of prophylactic antibiotics when umbilical artery catheters are
inserted in newborn infants, or to support or refute continuing antibiotics once initial cultures rule out infection in newborn infants
with umbilical artery catheters.
P L A I N L A N G U A G E S U M M A R Y
There is no evidence from randomised trials to either support or refute the routine use of preventive antibiotics in newborn babies with
umbilical artery catheters.
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Sick newborn babies occasionally require the insertion of an umbilical artery catheter (a special drip that goes into the artery in the
umbilicus (belly button)). This allows fluid and medicines to be given and blood tests to be taken. Some people believe that antibiotics
should be given to all babies with umbilical artery catheters in order to reduce the chance of infection occurring. However, antibiotics
can have unwanted effects. The reviewers found no evidence from randomized trials to either support or refute the routine use of
antibiotics for all babies with umbilical artery catheters.
B A C K G R O U N D
Umbilical artery catheters are commonly used in the management
of newborn infants with respiratory distress and other potentially
life-threatening disorders. Infection related to the use of these
catheters may cause significant morbidity and mortality. Morbid-
ity may include increased duration of respiratory illness, including
chronic lung disease, and need for respiratory support; increased
length of hospital stay; and impaired neurodevelopmental out-
come. The extent of the problem of infection related to umbilical
artery catheters is largely unknown due to the widespread use of
antibiotics in the population of infants who have umbilical artery
catheters.
Patients requiring umbilical artery catheters may, by virtue of their
underlying illness, have impaired defence mechanisms - both local
and systemic. Prematurity is recognised as a risk factor for late onset
sepsis (Dear 1999). Preterm neonates are at high risk of infection
because of impaired immunity and umbilical artery catheters may
further increase this risk because they are foreign bodies.
It is common practice in neonatal units to start antibiotics in
infants with respiratory distress and suspected infection. Many
of these infants will have an umbilical artery catheter inserted.
It is not clear whether antibiotics should be discontinued if no
infection is proven. It has been common practice in some units
that if the infant has an umbilical artery catheter then antibiotics
be continued in order to reduce the rate of colonisation of the
umbilicus and likewise reduce the risk of acquired infection (van
Vliet 1973).
Prophylactic antibiotics may prevent colonisation of the umbilicus
or umbilical artery catheters (Adam 1982) but may not decrease
infection and infection-related morbidity and mortality. In an ob-
servational study, Krauss et al (Krauss 1970) found no reduction
in catheter contamination with antibiotic use. Landers et al (Lan-
ders 1991) found in an observational study that a longer duration
of antibiotic therapy was significantly associated with increased
risk for umbilical arterial catheter-related sepsis, but found no link
between duration of catheter placement and sepsis. A policy of
prophylactic antibiotic use should take into account the possibil-
ity of encouraging increased resistance among pathogenic bacteria
(Dear 1999), which may vary between different antibiotics.
O B J E C T I V E S
The primary objective was to assess whether prophylactic antibi-
otics, in neonates with umbilical artery catheters, reduce mortality
and morbidity.
In separate comparisons, we planned to review two different poli-
cies regarding the prophylactic use of antibiotics in neonates with
umbilical artery catheters:
1) among neonates with umbilical artery catheters, a policy of pro-
phylactic antibiotics for the duration of catheterisation (or other
fixed duration of antibiotic treatment) versus placebo or no treat-
ment. This addresses the question of whether or not neonates with
umbilical artery catheters, who do not have clinical or laboratory
evidence of infection at that time, should be routinely started on
antibiotics at the time of catheterisation.
2) among neonates with umbilical artery catheters who had been
started on antibiotics at the time of catheterisation but whose
initial cultures to rule out sepsis are negative, a policy of continuing
versus discontinuing prophylactic antibiotics. This addresses the
question of whether or not antibiotics should routinely be stopped
at the time rule out sepsis cultures are reported as negative.
Data permitting, subgroup analyses were planned to determine
whether results differ by:
gestational age (e.g., preterm versus term, <28 weeks gestational
age (GA) or not, <32 weeks GA or not);
type of antibiotic (e.g., penicillins, macrolides, aminoglycosides,
cephalosporins, or combinations).
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
Randomised controlled trials, of adequate quality, in which either
individual newborn infants or clusters of infants are randomised
to receive prophylactic antibiotics versus placebo or no treatment.
Trials where the cluster unit is time were not included (as this
would not allow the assessment of antibiotic resistance).
Types of participants
Neonates with umbilical artery catheters.
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Types of intervention
Any antibiotic, or combination of antibiotics, versus placebo or no
treatment. This could include: 1) a policy of all neonates with um-
bilical artery catheters having antibiotics compared with placebo
or no treatment; or 2) a policy of neonates with umbilical artery
catheters continuing on antibiotics, once initial cultures to rule
out sepsis are negative, compared with ceasing antibiotics and con-
tinuing on placebo and/or no treatment.
Types of outcome measures
Primary:
• Mortality (neonatal, at hospital discharge, or at 1 year, 18
months, 2 years, or 5 years)
• Proven septicaemia (blood culture positive) or either suspected
septicaemia or clinical septicaemia (however defined in individ-
ual studies)
Secondary:
• Chronic lung disease (oxygen requirement at 36 weeks post-
menstrual age)
• Duration of ventilation (hours or days)
• Duration of respiratory support (hours or days)
• Duration of oxygen therapy (hours or days)
• Duration of hospital stay (days)
• Number of resistant organisms (i.e., species) identified per time
period per infant or per cluster unit
• Neurodevelopmental outcome (cerebral palsy, sensorineural
hearing loss, visual impairment and/or developmental delay -
at 1 year, 18 months, 2 years, or 5 years)
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: Neonatal Group methods used in reviews.
The standard search strategy for the Cochrane Neonatal Review
Group was used. Searches were done of MEDLINE from 1966 to
February 2004, CINAHL from 1982 to February 2004, and the
Cochrane Central Register of Controlled Trials (CENTRAL, The
Cochrane Library, Issue 1, 2004) using the following strategy:
MeSH search terms (“Umbilicus” AND “Catheterization”) OR
the textwords (“umb$” AND (“cathet$” OR “cannul$”)) OR
“UAC” OR “umbilical artery catheter”
AND
MeSH search term “Infant, newborn” OR the textwords
“neonat$” OR “infant”’
AND
MeSH search term “Antibiotics” OR the textword “antibiotic”
AND
MeSH search terms “Chemoprevention” OR “Antibiotic Prophy-
laxis” OR the textword “prophyl$”.
We also searched previous reviews (including cross references).
Searches were not restricted to publications in the English language
or published data.
M E T H O D S O F T H E R E V I E W
Criteria and methods used to assess the methodological quality of
the trials: standard methods of the Cochrane Collaboration and
its Neonatal Review Group were used.
The two reviewers independently searched for and assessed trials
for inclusion and methodological quality. Studies were assessed for
methodological quality using the following key criteria: allocation
concealment (blinding of randomisation), blinding of interven-
tion, completeness of follow up and blinding of outcome mea-
surement.
D E S C R I P T I O N O F S T U D I E S
Using the above search strategy we found four potentially eligible
reports. Wesstrom and Finnstrom (Wesstrom 1979) reported on a
case series of infants with umbilical artery catheters and Pulido et al
(Pulido 1985) studied umbilical venous catheters. Two controlled
trials (Bard 1973; Cowett 1977) were also excluded from analysis
(see Table: Characteristics of Excluded Studies) because they were
non-randomised (quasi-randomised) controlled trials - these trials
are described below, in Discussion. We found no studies that met
the criteria for inclusion in this review.
M E T H O D O L O G I C A L Q U A L I T Y
No randomised controlled trials were found for inclusion in this
review.
R E S U L T S
No randomised controlled trials were found for inclusion in this
review.
D I S C U S S I O N
This review has attempted to determine whether prophylactic an-
tibiotics are warranted in either of two circumstances:
1. should infants with umbilical artery catheters be commenced on
routine prophylactic antibiotics at the time of catheter insertion?
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2. should infants with umbilical artery catheters, who are com-
menced on antibiotics pending investigation results, be continued
on antibiotics once initial infection is ruled out?
A major limiting factor in trying to determine the place of prophy-
lactic antibiotics in infants with umbilical artery catheters is that
catheter placement is quite often undertaken, for ease of blood
sampling, in the context of clinical signs (e.g., respiratory distress)
which may reflect infection. Newborn infants with such illnesses
are usually commenced on antibiotics because those problems may
indicate infection at the same time that they may lead to the de-
cision to insert an umbilical artery catheter. Because the majority
of newborns in whom umbilical artery catheters are placed would
be treated in this way, the first scenario described above would be
relevant to relatively few newborns. The second scenario described
above would be the more common one encountered.
Two non-randomised (quasi-randomised) controlled trials study-
ing the use of prophylactic antibiotics for newborn infants with
umbilical artery catheters were found but excluded from analysis.
Bard et al (Bard 1973) alternately placed 75 infants with umbilical
artery catheters inserted for respiratory distress syndrome into a
treatment group receiving ampicillin and kanamycin, and a con-
trol group receiving no antibiotics. Blood cultures were obtained
from the umbilical artery catheters at insertion and just prior to
removal, and from a peripheral site just prior to umbilical artery
catheter removal (3 of 75 cultures were positive, all in the control
group). The umbilical artery catheter tip was sent for culture after
removal. They showed a statistically significant decrease in pos-
itive cultures drawn from the umbilical artery catheters in those
on antibiotics (predominantly Staph. epidermidis). There were no
statistically significant differences in positive (for pathogenic bac-
teria) blood cultures from umbilical artery catheters or in overall
mortality during the study period. No mention is made of length
of follow up.
Cowett et al (Cowett 1977) allocated 137 infants requiring um-
bilical artery catheterisation to different policies of antibiotic use
according to even or odd birth dates: if born on even dates (n=54),
routine penicillin and kanamycin; if born on odd birth dates (n=
79), selective antibiotics, ie no routine antibiotics unless their
physician requested antibiotics because of suspected infection.
(Twenty-five of the 79 babies in the latter group did receive antibi-
otics because of suspected infection.) Blood cultures were drawn
from a peripheral vein and the catheter at the time of catheter inser-
tion, and again at removal. At removal, none of the 36 peripheral
blood cultures which were obtained were positive in the routine
antibiotics group; whereas 3 of 53 peripheral blood cultures were
positive in the selective antibiotics group. Of these positive blood
cultures, one was considered a contaminant, while the other two
did not match umbilical artery catheter tip culture results and were
therefore deemed not to reflect cannula sepsis. Death occurred in
9 of 58 infants in the routine antibiotics group (15.5%) , and 8
of 79 in the selective antibiotics group (10.1%): this was not a
statistically significant difference. No mention is made of length
of follow-up.
The authors of both of these non-randomised (quasi-randomised)
studies conclude that there is no evidence to support the use of
prophylactic antibiotics in infants with umbilical artery catheters.
However, the results should be treated with caution, as they are
prone to significant bias. Specifically, with alternate group assign-
ment, if 2 equally eligible infants present at the same time with
different risks for infection a clinician might (consciously or not)
enter them into the study in the order that would allow the infant
that they believed should receive antibiotics to get antibiotics. If
a large number of infants were enrolled in this way serious imbal-
ance in the treatment groups with respect to factors affecting the
outcome would result (Hennekens 1987). Similarly, with alternate
day assignment, clinicians may or may not enrol infants into the
study if they believe that the infant should be or not be in the
group allocated for that day.
In order to justify the use of prophylactic antibiotics (rather than
treatment of infection as it arises) in infants with umbilical artery
catheters there should be evidence that the benefit outweighs the
harm. This should include an adequate assessment not only of
short term outcomes such as infection rate and duration of hospital
admission, but also of long term outcomes such as mortality, long
term respiratory morbidity and neurodevelopmental outcome.
Theoretical concerns about the potential harm of prophylactic an-
tibiotic use include antibiotic resistance, superinfection and drug
toxicity. Altered antibiotic resistance patterns may be of conse-
quence not only to the individual in whom prophylactic antibi-
otics are used but also to other patients within the hospital setting
and to the wider community.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
• There is no evidence from randomised trials to support or re-
fute the use of prophylactic antibiotics when inserting umbilical
artery catheters in newborn infants.
• There is no evidence from randomised trials to support or refute
continuing antibiotics once initial cultures rule out infection in
newborn infants with umbilical artery catheters.
Implications for research
• If prophylactic antibiotics are to be considered when inserting
umbilical artery catheters then good quality randomised con-
trolled trials are required to show that their benefits outweigh
the harms. Unfortunately, most newborn infants who have um-
bilical artery catheters inserted are likely to receive antibiotics to
cover possible infection and a randomised controlled trial may
not be practicable or ethical.
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• A more pressing question is whether infants who initially re-
ceive antibiotics for presumed infection should be continued on
antibiotics once initial cultures rule out infection. Good quality
randomised controlled trials are required to address this issue.
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T A B L E S
Characteristics of excluded studies
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Pulido 1985 Not a randomised controlled trial - only studied umbilical venous catheters.
Wesstrom 1979 Not a controlled trial - reported on a case series of infants with umbilical artery catheters.
G R A P H S A N D O T H E R T A B L E S
This review has no analyses.
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Humans
C O V E R S H E E T
Title Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery
catheters
Authors Inglis GDT, Davies MW
Contribution of author(s) GDI & MWD searched for studies and assessed studies for inclusion
GDI wrote the review
MWD co-wrote the review
Issue protocol first published 2004/2
Review first published 2004/3
Date of most recent amendment 25 May 2004
Date of most recent
SUBSTANTIVE amendment
26 March 2004
What’s New Information not supplied by author
Date new studies sought but
none found
Information not supplied by author
Date new studies found but not
yet included/excluded
Information not supplied by author
Date new studies found and
included/excluded
Information not supplied by author
6Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery catheters (Review)
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Date authors’ conclusions
section amended
Information not supplied by author
Contact address Dr Garry Inglis
Neonatal Fellow
Department of Pediatrics
McMaster University
1200 Main Street West
Hamilton
Ontario
L8N 3Z5
CANADA
E-mail: inglisgd@mcmaster.ca
Tel: 905 521 2100
DOI 10.1002/14651858.CD004697.pub2
Cochrane Library number CD004697
Editorial group Cochrane Neonatal Group
Editorial group code HM-NEONATAL
7Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery catheters (Review)
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
